CRISPR (Clustered Regularly Interspaced Short Palindromic Repeats)-Cas (CRISPR-associated) systems, originally identified as prokaryotic adaptive immune mechanisms, have rapidly evolved into powerful tools for molecular diagnostics. Leveraging their precise nucleic acid targeting capabilities, CRISPR diagnostics offer rapid, sensitive, and specific detection solutions for a wide array of targets. This review delves into the fundamental principles of various Cas proteins (e.g., Cas9, Cas12a, Cas13a) and their distinct mechanisms of action (cis- and trans-cleavage). It highlights the diverse applications spanning infectious disease surveillance, cancer biomarker detection, and genetic disorder screening, emphasizing key advantages such as speed, high sensitivity, specificity, portability, and cost-effectiveness, particularly for point-of-care (POC) testing in resource-limited settings. The report also addresses current challenges, including sensitivity limitations without pre-amplification, specificity issues, and complex sample preparation, while exploring promising future trajectories like the integration of artificial intelligence (AI) and the development of universal diagnostic platforms to enhance clinical translation.
We show that the extracted native chromatin presents a bifurcated hierarchical structure. The transitional 30 nm chromatin branching structure is the penultimate structure presenting 30 nm chromatin fiber unwinding into multiple nucleosomal arrays. Some nucleosomal arrays form the helix ribbon structure, while others randomly twist. Our work provides structural insights on the regulation of eukaryotic transcription.
Interphase chromatin in mammalian cells is spatially organized in a hierarchical branching manner allowing easy genomic transition from lower order nucleosomal arrays to higher order heterochromatin.